查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654424

體外診斷契約製造市場規模、佔有率、趨勢分析報告：按產品、服務、技術、最終用途、地區、細分市場預測，2025-2030 年

In Vitro Diagnostics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Instruments, Software & Services), By Service, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

體外診斷契約製造市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，全球體外診斷契約製造市場規模預計到2030年將達到374.5億美元，2025年至2030年期間的複合年成長率為10.4%。

由於對診斷設備的需求不斷增加、照護現場的激增、分子檢測的進步以及慢性病患病率的不斷上升，預計市場將經歷良好的成長。此外，對診斷藥物成本效益製造、技術創新和嚴格合規性的需求不斷成長，預計將增加市場收益。因此，醫療公司越來越傾向於將製造服務外包給 CMO/CDMO，以利用專業知識、簡化生產流程並加快產品上市時間，從而推動整體市場成長。

體外診斷試劑內部製造成本高是推動市場成長的主要因素。擴大體外診斷的開發和生產需要在基礎設施、專用設備、法規遵循和熟練勞動力方面進行昂貴的資本投資，這推動了市場的成長。這些間接費用會造成資源緊張，進而降低中小型組織的盈利和靈活性。因此，透過將製造服務外包給 CMO 或 CDMO，公司可以降低製造成本並獲得創新技術，而無需內部資本投資。此外，外包可以加快市場進入速度、提高可擴展性和最佳化資源，從而增加 IVD 市場的競爭。

此外，持續的技術進步是加速市場需求的主要因素之一，尤其是對診斷設備和測試解決方案的需求。分子診斷、次世代定序（NGS）和自動化等技術進步正在提高體外診斷製造流程的準確性、速度和效率。這些進步正在幫助製造商滿足對個人化醫療、照護現場診斷和更快疾病檢測方法日益成長的需求。此外，主導技術與資料分析的整合最佳化了製造工作流程和品質保證流程，提高了準確性和對監管標準的遵守程度。此外，許多醫療公司正在與契約製造製造商合作，以獲得此類新技術，以加快產品上市時間、降低營運成本並提高產品的可擴展性。因此，服務供應商對先進技術的整合預計將在未來幾年推動市場成長。

體外診斷契約製造市場報告重點

  • 按產品類型分類，包括儀器、試劑和消耗品、軟體和服務。 2024 年，試劑和消耗品部門佔最大收益佔有率，為 69.41%。
  • 按服務分類，分為製造服務、分析開發服務和其他服務。預計製造服務將在 2024 年佔據最大的市場佔有率。
  • 根據技術，市場分為免疫檢測、臨床化學、分子診斷、血液學、微生物學、凝血等。免疫檢測領域將在 2024 年佔據最大的收入佔有率，主導市場。
  • 根據最終用途，市場分為醫療設備公司、學術和研究機構以及其他。 2024年，醫療設備公司佔據最大的收益佔有率。
  • 2024 年北美體外診斷契約製造市場佔據全球市場主導地位，佔有 41.83% 的最大佔有率。預計亞太地區體外診斷契約製造市場在預測期內將實現最快的複合年成長率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章體外診斷契約製造市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 技術格局
  • 定價模式分析
  • 產業生態系統分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章體外診斷契約製造市場：按產品分類的估計和趨勢分析

  • 體外診斷契約製造市場（按產品分類）：細分儀表板
  • 體外診斷契約製造市場（依產品分類）：變異分析
  • 依產品分類，2018-2030 年
  • 裝置
  • 試劑和耗材
  • 軟體和服務

第 5 章體外診斷契約製造市場：按服務分類的估計和趨勢分析

  • 體外診斷契約製造市場（按服務）：細分儀表板
  • 體外診斷契約製造市場（按服務）：變化分析
  • 按服務分類，2018-2030 年
  • 製造服務
  • 檢測開發服務
  • 其他

第 6 章體外診斷契約製造市場：按技術分類的估計和趨勢分析

  • 體外診斷契約製造市場（按技術分類）：細分儀表板
  • 體外診斷契約製造市場（按技術分類）：差異分析
  • 依技術分類，2018-2030 年
  • 免疫檢測
  • 臨床化學
  • 分子診斷
  • 血液學
  • 微生物學
  • 凝血
  • 其他

第 7 章體外診斷契約製造市場：按最終用途進行的估計和趨勢分析

  • 體外診斷契約製造市場（按最終用途）：細分儀表板
  • 體外診斷契約製造市場（依最終用途）：變化分析
  • 按最終用途分類，2018-2030 年
  • 醫療設備公司
  • 學術和研究機構
  • 其他

第 8 章：體外診斷契約製造市場：按地區分類的估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 市場參與企業分類
    • 市場領導者
    • 新參與企業
  • 2024 年服務熱圖分析
  • 公司簡介
    • Jabil Inc.
    • Sanmina Corporation
    • TE Connectivity
    • Celestica Inc.
    • Savyon Diagnostics
    • West Pharmaceutical Services, Inc.
    • Thermo Fisher Scientific
    • KMC Systems
    • Cenogenics Corporation
    • Novo Biomedical
    • Cone Bioproducts
    • Invetech
    • AVIOQ Inc.
    • Meridian Bioscience Inc.
    • Nemera
Product Code: GVR-4-68040-462-6

In Vitro Diagnostics Contract Manufacturing Market Growth & Trends:

The global in vitro diagnostics contract manufacturing market size is expected to reach USD 37.45 billion by 2030, registering a CAGR of 10.4% from 2025 to 2030, according to a new report by Grand View Research, Inc.

The market is anticipated to witness lucrative growth potential owing to rising demand for diagnostic devices, an upsurge in point-of-care diagnostics, advancements in molecular testing, and the increasing prevalence of chronic diseases. Moreover, the growing need for cost-effective manufacturing, technological innovation, and stringent regulatory compliance for diagnostics is expected to drive the market revenue stream. Thus, the increasing trend for outsourcing manufacturing services to CMOs and CDMOs to access specialized expertise, streamline production, and accelerate time-to-market among healthcare companies is boosting overall market growth.

The high cost of in-house IVD manufacturing is a significant driver propelling the market growth. The need for high capital investment in infrastructure, specialized equipment, regulatory compliance, and skilled workforce to develop and scale up IVD production will accelerate market growth. These overhead costs strain resources, reducing profitability and flexibility among several small and medium-scale organizations. Thus, by outsourcing manufacturing services to CMOs & CDMOs, companies can lower manufacturing costs and gain access to innovative technologies exclusive of the need for internal capital investment. Moreover, outsourcing allows faster market entry, enhanced scalability, and better resource optimization and offers a competitive edge in the IVD market.

Furthermore, continuous technological advancements are among the major factors accelerating the market demand, specifically for diagnostic devices and testing solutions. Innovations such as molecular diagnostics, next-generation sequencing (NGS), and automation have enhanced the accuracy, speed, and efficiency of IVD manufacturing processes. These advancements assist manufacturers to meet the increasing demand for personalized medicine, point-of-care diagnostics, and faster disease detection methods. Moreover, the integration of AI-driven technologies and data analytics optimizes production workflows and quality assurance processes, enhancing precision and compliance with regulatory standards. Furthermore, numerous healthcare companies are involved in collaboration with contract manufacturers to access such novel technologies to accelerate time-to-market, reduce operational costs, and enhance product scalability. Thus, the integration of advanced technologies by service providers is estimated to drive market growth in the forthcoming years.

In Vitro Diagnostics Contract Manufacturing Market Report Highlights:

  • Based on product, the market includes instruments, reagents & consumables, software & services. In 2024, the reagents & consumables segment accounted for the largest revenue share of 69.41%.
  • Based on service, the market is segmented into manufacturing services, assay development services, and other services. The manufacturing services segment accounted for the largest market share in 2024.
  • Based on technology, the market is segmented into immunoassays, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation, and others. The immunoassays segment dominated the market with the largest revenue share in 2024.
  • In terms of end use, the market is segmented into medical device companies, academic & research institutions, and others. The medical device companies segment dominated the market with the largest revenue share in 2024.
  • North America in vitro diagnostics contract manufacturing market dominated the global market in 2024 with the largest share of 41.83%. The in vitro diagnostics contract manufacturing market in Asia Pacific is expected to witness the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Industry Ecosystem Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. In Vitro Diagnostics (IVD) Contract Manufacturing Market: Phases Estimates & Trend Analysis

  • 4.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Segment Dashboard
  • 4.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Movement Analysis
  • 4.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Reagents & Consumables
    • 4.5.1. Reagents & Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Software & Services
    • 4.6.1. Software & Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics (IVD) Contract Manufacturing Market: Service Estimates & Trend Analysis

  • 5.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Segment Dashboard
  • 5.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Movement Analysis
  • 5.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Manufacturing Services
    • 5.4.1. Manufacturing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Assay Development Services
    • 5.5.1. Assay Development Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Other Services
    • 5.6.1. Other Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics (IVD) Contract Manufacturing Market: Technology Estimates & Trend Analysis

  • 6.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Segment Dashboard
  • 6.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Movement Analysis
  • 6.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Technology, 2018 - 2030
  • 6.4. Immunoassays
    • 6.4.1. Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical Chemistry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Molecular Diagnostics
    • 6.6.1. Molecular Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Hematology
    • 6.7.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Microbiology
    • 6.8.1. Microbiology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Coagulation
    • 6.9.1. Coagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In Vitro Diagnostics (IVD) Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 7.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Segment Dashboard
  • 7.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Movement Analysis
  • 7.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Medical Device Companies
    • 7.4.1. Medical Device Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutions
    • 7.5.1. Academic & Research Institutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In Vitro Diagnostics (IVD) Contract Manufacturing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Service Heat Map Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Jabil Inc.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Sanmina Corporation
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. TE Connectivity
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Celestica Inc.
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Savyon Diagnostics
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. West Pharmaceutical Services, Inc.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Thermo Fisher Scientific
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. KMC Systems
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Cenogenics Corporation
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Novo Biomedical
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Cone Bioproducts
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Invetech
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. AVIOQ Inc.
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. Meridian Bioscience Inc.
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. Nemera
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives

List of Tables

  • Table. 1 Market segmentation
  • Table. 2 Market research process
  • Table. 3 Information procurement
  • Table. 4 Primary research pattern
  • Table. 5 Market research approaches
  • Table. 6 Value chain-based sizing & forecasting
  • Table. 7 QFD modelling for market share assessment
  • Table. 8 Market formulation & validation
  • Table. 9 In Vitro Diagnostics (IVD) contract manufacturing market revenue, 2018 - 2030 (USD Million)
  • Table. 10 In Vitro Diagnostics (IVD) contract manufacturing market snapshot
  • Table. 11 In Vitro Diagnostics (IVD) contract manufacturing market driver impact
  • Table. 12 In Vitro Diagnostics (IVD) contract manufacturing market restraint impact
  • Table. 13 In Vitro Diagnostics (IVD) contract manufacturing sector key takeaways (USD Million)
  • Table. 14 In Vitro Diagnostics (IVD) contract manufacturing Market: Product movement analysis
  • Table. 15 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 16 Reagents & consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 17 Software & services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 18 In Vitro Diagnostics (IVD) contract manufacturing market service key takeaways (USD Million)
  • Table. 19 In Vitro Diagnostics (IVD) contract manufacturing market: service movement analysis
  • Table. 20 Manufacturing services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 21 Assay development services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 22 Other services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 23 In Vitro Diagnostics (IVD) contract manufacturing market technology key takeaways (USD Million)
  • Table. 24 In Vitro Diagnostics (IVD) contract manufacturing market: technology movement analysis
  • Table. 25 Immunoassays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 26 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 27 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 28 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 29 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 30 Coagulation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 32 In Vitro Diagnostics (IVD) contract manufacturing market end use key takeaways (USD Million)
  • Table. 33 In Vitro Diagnostics (IVD) contract manufacturing market: end use movement analysis
  • Table. 34 Medical device companies' market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 35 Academic & research institutions market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 37 Regional marketplace: Key takeaways
  • Table. 38 Regional outlook, 2024 & 2030
  • Table. 39 North America In Vitro Diagnostics (IVD) contract manufacturing Market, 2018 - 2030 (USD Million)
  • Table. 40 U.S. In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 41 Canada In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 42 Mexico In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 43 Europe In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 44 UK In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 45 Germany In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 46 France In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 47 Italy In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 48 Spain In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 49 Sweden In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 50 Denmark In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 51 Norway In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 52 Asia Pacific In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 53 Japan In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 54 China In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 55 India In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 56 Thailand In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 57 South Korea In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 58 Australia In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 59 Latin America In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 60 Brazil In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 61 Argentina In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 62 Middle East & Africa In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 63 South Africa In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 64 Saudi Arabia In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 65 UAE In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 66 Kuwait In Vitro Diagnostics (IVD) contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Table. 67 Market participant categorization

List of Figures

  • Fig. 1 List of Tables
  • Fig. 2 List of Secondary Sources
  • Fig. 3 List of Abbreviations
  • Fig. 4 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 5 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 6 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 7 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 8 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
  • Fig. 9 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 10 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 11 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 12 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 13 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 14 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 18 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 19 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 20 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 21 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 22 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 23 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 24 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 26 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 27 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 28 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 29 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 30 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 31 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 32 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 33 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 34 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 35 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 36 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 37 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 38 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 39 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 40 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 41 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 42 France In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 43 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 44 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 45 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 46 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 47 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 48 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 49 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 50 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 59 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 60 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 61 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 62 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 63 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 68 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 69 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 70 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 71 China In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 72 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 73 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 74 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 75 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 76 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 77 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 78 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 79 India In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 81 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 83 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 84 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 85 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 86 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 87 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 89 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 90 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 94 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 95 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 96 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 97 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 98 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 100 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 102 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 103 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 104 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 105 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
  • Fig. 106 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 107 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 108 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 109 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 110 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 111 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 112 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 114 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 115 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 117 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 118 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 119 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 120 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 121 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
  • Fig. 123 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
  • Fig. 124 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
  • Fig. 125 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)